Basel Medical Group has agreed to acquire Singapore healthcare provider Bethesda Medical, while Indonesia’s Surge has agreed to an investment by Japan’s Nippon Telegraph and Telephone East.

Compared with emergency medical service CPR, longer return of spontaneous circulation was seen with layperson-initiated bystander life support (20 vs 5 minutes). HealthDay News — For patients with out ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Find events near you and more with AARP Local. Help Register ...

Medical Dialogues team had earlier reported that the Company ... Read also: Zydus Lifesciences bags USFDA nod for prostate cancer drug Apalutamide Zydus Lifesciences Ltd. is an innovative, global ...

according to a final recommendation statement published in the Journal of the American Medical Association. Carrie D. Patnode, PhD, MPH, from the Kaiser Permanente Evidence-based Practice Center ...

Within the 5 years following hospital-based for cannabis-use disorder care, 3770 individuals died compared to 2550 members of the general population. Individuals requiring emergency or hospital ...

Increased odds of current asthma and wheeze seen at 4 to 6 years of age, but associations were null for outcomes at 8 to 9 years of age. “This analysis underscores the importance of better ...

Results from the trial will be presented at an upcoming medical meeting. If approved, belzutifan would be the first available therapy in the US for these rare neuroendocrine tumors. The randomized, ...

Switching to tirzepatide was linked to additional reduction in HbA1c and weight loss compared with escalating dulaglutide. HealthDay News — For patients with inadequately controlled type 2 diabetes ...

The extended-release delivery coupled with the 351mg dose allows for single-dose initiation. Erzofri ® (paliperidone palmitate) extended-release injectable suspension is now available for the the ...

A Prescription Drug User Fee Act target date of July 28, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has granted Priority Review to pegcetacoplan for the ...

Global R&D and Chief Medical Officer at Teva. “If approved, Ajovy could be an important step toward filling the gap in pediatric migraine care, offering a much-needed solution for this ...